Thatcher, N., & Thomas, M. (2019). Efficacy and safety of the biosimilar ABP 215 compared with Bevacizumab in patients with advanced nonsquamous non-small cell lung cancer (MAPLE): A randomized, double-blind, phase III study. Clinical cancer research, 25(7), . https://doi.org/10.1158/1078-0432.CCR-18-2702
Chicago-Zitierstil (17. Ausg.)Thatcher, Nicholas, und Michael Thomas. "Efficacy and Safety of the Biosimilar ABP 215 Compared with Bevacizumab in Patients with Advanced Nonsquamous Non-small Cell Lung Cancer (MAPLE): A Randomized, Double-blind, Phase III Study." Clinical Cancer Research 25, no. 7 (2019). https://doi.org/10.1158/1078-0432.CCR-18-2702.
MLA-Zitierstil (9. Ausg.)Thatcher, Nicholas, und Michael Thomas. "Efficacy and Safety of the Biosimilar ABP 215 Compared with Bevacizumab in Patients with Advanced Nonsquamous Non-small Cell Lung Cancer (MAPLE): A Randomized, Double-blind, Phase III Study." Clinical Cancer Research, vol. 25, no. 7, 2019, https://doi.org/10.1158/1078-0432.CCR-18-2702.